Correction to: Sutimlimab improves quality of life in patients with cold agglutinin disease: results of patientreported outcomes from the CARDINAL study.

Autor: Röth A; Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany. alexander.roeth@uk-essen.de., Barcellini W; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Anderson Tvedt TH; Section for Hematology, Department of Medicine, Haukeland University Hospital, Bergen, Norway., Miyakawa Y; Department of General Internal Medicine, Saitama Medical University Hospital, Saitama, Japan., Kuter DJ; Division of Hematology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Su J; Sanof, Cambridge, MA, USA., Jiang X; Sanof, Cambridge, MA, USA., Hobbs W; Sanof, Cambridge, MA, USA., Morales J; Sanof, Cambridge, MA, USA., Shafer F; Sanof, Cambridge, MA, USA., Weitz IC; Jane Anne Nohl Division of Hematology, Department of Medicine, University of Southern California - Keck School of Medicine, Los Angeles, CA, USA.
Jazyk: angličtina
Zdroj: Annals of hematology [Ann Hematol] 2024 May; Vol. 103 (5), pp. 1803.
DOI: 10.1007/s00277-024-05709-9
Databáze: MEDLINE